Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation

NCT04687111 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Atrial Remodeling
Myocardial Dysfunction
Left Ventricular Remodeling
Left Ventricular Diastolic Dysfunction
Hypertension
Cardiovascular Morbidity
Fibrosis Myocardial
Inflammatory Myopathy
Atrial Arrhythmia

Interventions

DRUG: Sacubitril-Valsartan
DRUG: Valsartan

Sponsor

Mark Ledwidge

Collaborators

[object Object]